Mitochondriopathy: A rare aetiology of restrictive cardiomyopathy

European Journal of Echocardiography

Volumn 9, Issue 6, 2008, Pages 840-845

  Thebault, Christophe ^a   Ollivier, Romain ^a   Leurent, Guillaume ^a   Marcorelles, Pascale ^b   Langella, Bernard ^a   Donal, Erwan ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Heart failure; Mitochondriopathy; Restrictive cardiomyopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; UBIDECARENONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; HUMAN TISSUE; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SALIVARY GLAND BIOPSY; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

CARDIOMYOPATHY, RESTRICTIVE; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; MITOCHONDRIA, HEART; MITOCHONDRIAL DISEASES; POINT MUTATION;

EID: 54949109066     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jen189     Document Type: Article

References (11)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-16.
2. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74.
3. Donovan LE, Severin NE. Maternally inherited diabetes and deafness in a North American kindred: tips for making the diagnosis and review of unique management issues. J Clin Endocrinol Metab 2006;91:4737-42.
4. Suzuki S, Hinokio Y, Ohtomo M, Hirai M, Hirai A, Chiba M et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 1998;41:584-8.
5. Salles JE, Moises VA, Almeida DR, Chacra AR, Moises RS. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10. Diabetes Res Clin Pract 2006;72:100-3.
6. Mangiafico RA, Zeviani M, Bartoloni G, Fiore CE. Accelerated cardiomyopathy in maternally inherited diabetes and deafness. Int J Clin Pharmacol Res 2004;24:15-21.
7. Ohmoto N, Fujiwara Y, Kibira S, Kobayashi M, Saito T, Miura M. Cardiomyopathy showing progression from diffuse left ventricular hypertrophy to dilated phase associated with mitochondrial DNA point mutation A3243G: a case report. J Cardiol 2003;41:21-7.
8. Nijveldt R, Serne EH, Sepers JM, Maassen JA, Cornel JH, Arnold AE. A man with diabetes and heart failure. Lancet 2004;364:636.
9. Ueno H, Shiotani H. Cardiac abnormalities in diabetic patients with mutation in the mitochondrial tRNA(Leu(UUR)) gene. Jpn Circ J 1999;63:877-80.
10. Momiyama Y, Atsumi Y, Ohsuzu F, Ui S, Morinaga S, Matsuoka K et al. Rapid progression of cardiomyopathy in mitochondrial diabetes. Jpn Circ J 1999;63:130-2.
11. Abergel E, Cohen A, Gueret P, Roudaut R. Echocardiographie de l'adulte. Estem Editions. 2003.